The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Warrender-Sparkes, Matthew; Spelman, Tim; Izquierdo, Guillermo; Trojano, Maria; Lugaresi, Alessandra; Grand'Maison, Francois; Havrdova, Eva; Horakova, Dana; BOZ, CAVİT; Oreja-Guevara, Celia; Alroughani, Raed; Iuliano, Gerardo; Duquette, Pierre; Girard, Marc; TERZİ, MURAT; Hupperts, Raymond; Grammond, Pierre; Petersen, Thor; Fernandez-Bolanos, Ricardo; Fiol, Marcela; Pucci, Eugenio; Lechner-Scott, Jeannette; Verheul, Freek; Cristiano, Edgardo; Van Pesch, Vincent; Petkovska-Boskova, Tatjana; Moore, Fraser; Kister, Ilya; Bergamaschi, Roberto; Laura Saladino, Maria; Slee, Mark; Barnett, Michael; Amato, Maria; Shaw, Cameron; Shuey, Neil; Young, Carolyn; Gray, Orla; Kappos, Ludwig; Butzkueven, Helmut; Kalincik, Tomas; Jokubaitis, Vilija

doi:10.1177/1352458515594041

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Warrender-Sparkes M., Spelman T., Izquierdo G., Trojano M., Lugaresi A., Grand'Maison F., ...Daha Fazla

MULTIPLE SCLEROSIS JOURNAL, cilt.22, sa.4, ss.520-532, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 22 Sayı: 4
Basım Tarihi: 2016
Doi Numarası: 10.1177/1352458515594041
Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.520-532
Anahtar Kelimeler: Multiple sclerosis, disease-modifying therapy, fingolimod, medication persistence, MSBase, DISEASE-MODIFYING THERAPIES, INTERFERON-BETA THERAPY, TREATMENT PATTERNS, ADHERENCE, FINGOLIMOD, NATALIZUMAB
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objective: We aimed to analyse the effect of the introduction of fingolimod, the first oral disease-modifying therapy, on treatment utilisation and persistence in an international cohort of patients with multiple sclerosis (MS).